Question 1

How does EquitAI evaluate Quanex Building Products Corporation's (NX) valuation and Stock DNA?

Accepted Answer

Quanex Building Products Corporation (NX) trades at $20.67 with an EquitAI Valuation DNA score of 6/10 and Quality score of 2/10. The company's trailing P/E ratio is 20.8x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

Question 2

What sector and industry does Quanex Building Products Corporation (NX) operate in?

Accepted Answer

Quanex Building Products Corporation (NX) is classified under the Basic Materials sector within the Construction Materials industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Construction Materials peers and broader Basic Materials market benchmarks.

Question 3

What is Wall Street's price target and consensus rating for Quanex Building Products Corporation (NX)?

Accepted Answer

Wall Street analysts have a consensus 12-month price target of $27.3 for Quanex Building Products Corporation (NX), representing an implied 31.8% upside from its current trading level of $20.67 with an average rating of Hold. Individual analyst price targets range from a low of $25.0 to a high of $30.0, with a median forecast of $27.0. EquitAI benchmarks analyst consensus projections against intrinsic Financial DNA valuation pillars.

Question 4

Does NX pay dividends or capital distributions?

Accepted Answer

Quanex Building Products Corporation has an indicated annual dividend yield of 1.55%. Dividend stability is factored into its Income DNA pillar alongside free cash flow coverage.

Question 5

Who are Quanex Building Products Corporation's (NX) primary market competitors and peers?

Accepted Answer

Key market peers and semantic competitors include QXO, WLK, ROCK, RPM. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

Question 6

How should investors interpret EquitAI's NX analysis?

Accepted Answer

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

NX - Quanex Building Products Corporation Stock Analysis & Valuation

Quanex Building Products Corporation

FIT ANALYSIS